Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nordhealth ASOSL:NORDH -2.50%72 Receivables Turnover is 2.09 as of Jun. 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 72/100 and a GF Value™ of kr38.37 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 659 Healthcare Providers & Services companies, Nordhealth AS ranks better than 53.57% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Nordhealth AS's Revenue for the
three
months ended in Jun. 2026 was kr156.5 Mil. Nordhealth AS's average Accounts Receivable for the
three
months ended in Jun. 2026 was kr74.9 Mil.
Hence, Nordhealth AS's Receivables Turnover for the
three
months ended in Jun. 2026 was 2.09.
Nordhealth AS (OSL:NORDH) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Nordhealth AS Receivables Turnover Related Terms
Nordhealth AS Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Nordhealth AS's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:NORDH vs VEEV, BTSG, HQY: Receivables Turnover Comparison
For the Health Information Services subindustry, Nordhealth AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nordhealth AS Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nordhealth AS's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Nordhealth AS's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nordhealth AS (OSL:NORDH) has a Receivables Turnover of 2.09 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nordhealth AS and its competitors. According to the industry distribution chart, Nordhealth AS ranks #306 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 46.4%.
Is Nordhealth AS's Receivables Turnover too high?
Nordhealth AS's current Receivables Turnover is 2.09. The Healthcare Providers & Services industry median Receivables Turnover is 7.96. Nordhealth AS's value of 2.09 is 73.7% below this industry median. Based on the distribution chart, Nordhealth AS ranks #306 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nordhealth AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Receivables Turnover compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nordhealth AS ranks #306 out of 659 companies for Receivables Turnover. This puts Nordhealth AS in the upper half of its industry. The industry median Receivables Turnover is 7.96. Nordhealth AS's value of 2.09 is 73.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.96, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nordhealth AS's current Receivables Turnover of 2.09 is 73.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nordhealth AS and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nordhealth AS's current Receivables Turnover is 2.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr38.37, compared to a current price of kr23.40 — trading 39% below its estimated fair value. The current Receivables Turnover is 2.09 and 73.7% below the Healthcare Providers & Services industry median of 7.96. Nordhealth AS's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Receivables Turnover is 2.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?
Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued.
The current stock price of kr23.40 is trading 39% below its estimated GF Value™ of kr38.37.
GuruFocus considers Nordhealth AS to be Significantly Undervalued.
Key valuation signals for OSL:NORDH:
Receivables Turnover: 2.09
GF Value™: kr38.37 vs. price of kr23.40 (39% below fair value)
Industry Position: 73.7% below the Healthcare Providers & Services median (#306 of 659)
No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
72GF Score
Get the complete analysis for OSL:NORDH
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:NORDH has been successfully added to your 
